Anne-Catherine Jallas

Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells

Sandrine Valsesia‐Wittmann, Maud Magdeleine, Sébastien Dupasquier et al. · Cancer Cell · 2004 · 261 citations · Full text

Medicine, Cancer Biology, Molecular Biology +16

Repurposing rotavirus vaccines for intratumoral immunotherapy can overcome resistance to immune checkpoint blockade

Tala Shekarian, Éva Sivadó, Anne-Catherine Jallas et al. · Science Translational Medicine · 2019 · 74 citations · Full text

Medicine, Immunology, Oncology +17

TWIST1 is a direct transcriptional target of MYCN and MYC in neuroblastoma

Abdelkader Selmi, Maud de Saint-Jean, Anne-Catherine Jallas et al. · Cancer Letters · 2014 · 55 citations

Medicine, Molecular Biology, Oncology +12

In Vitro and In Vivo Comparison of Lymphocytes Transduced with a Human CD16 or with a Chimeric Antigen Receptor Reveals Potential Off-Target Interactions due to the IgG2 CH2-CH3 CAR-Spacer

Béatrice Clemenceau, Sandrine Valsesia‐Wittmann, Anne-Catherine Jallas et al. · Journal of Immunology Research · 2015 · 23 citations · Full text

Life Sciences, Cancer Biology, Immunology +16

Antibody and antibody fragments site-specific conjugation using new Q-tag substrate of bacterial transglutaminase

Meddy El Alaoui, Éva Sivadó, Anne-Catherine Jallas et al. · Cell Death Discovery · 2024 · 23 citations · Full text

Pharmacy, Biochemistry, Biotechnology +17